New Generics and Biosimilars = New Risks for Confusion
December 2025
More patients will be admitted on new generics or biosimilars...and you’ll need to watch for potential confusion or problems.
Generic liraglutide (Saxenda) is the first generic GLP-1 agonist for obesity. But don’t expect this daily injectable to be added to formulary. The generic still costs about $40/day versus $45/day for the brand.
On med histories, document the generic and brand name...PLUS the indication...to avoid confusion between different liraglutide products or the patient’s medical conditions.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote